Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Movement disorders and AIDS]

A Iranzo1, J Kulisevsky, J Cadafalch

  • 1Servicio de Neurología, Hospital de la Santa Creu i Sant Pau, Barcelona.

Neurologia (Barcelona, Spain)
|February 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cognitive and behavioral disturbances in PSP and MSA: clinical features and imaging correlates.

Journal of neural transmission (Vienna, Austria : 1996)·2026
Same author

Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older.

Actas dermo-sifiliograficas·2025
Same author

Consensus Document on the Clinical Management of Frontal Fibrosing Alopecia: Recommendations From Spanish Working Group on Trichology and Onychology of the AEDV.

Actas dermo-sifiliograficas·2025
Same author

The discriminative linguistic profiles of progressive supranuclear palsy and Parkinson's disease.

Neurologia·2025
Same author

Comments to Reply to "Differences in Molecular Sensitization Profiles Between Spanish and Latin American Mite-Allergic Patients".

Journal of investigational allergology & clinical immunology·2025
Same author

Exploring the impact of NGS on diagnostics and treatment of sarcoma: insights from real-world data across multiple institutions in Europe.

ESMO open·2025
Same journal

[Amyotrophic neuralgia secondary to Vaxzevria (AstraZeneca) COVID-19 vaccine].

Neurologia (Barcelona, Spain)·2024
Same journal

[SARS-CoV-2 infection: Possible underdiagnosis of cerebral venous sinus thrombosis].

Neurologia (Barcelona, Spain)·2024
Same journal

[Bell's palsy following COVID-19 vaccination: A case report].

Neurologia (Barcelona, Spain)·2024
Same journal

[Parsonage-Turner syndrome post-infection by SARS-CoV-2: A case report].

Neurologia (Barcelona, Spain)·2024
Same journal

[Acute transverse myelitis following SARS-CoV-2 infection].

Neurologia (Barcelona, Spain)·2024
Same journal

[Neurological complications in critical patients with COVID-19].

Neurologia (Barcelona, Spain)·2024
See all related articles

Movement disorders in patients with Acquired Immunodeficiency Syndrome (AIDS) are often caused by basal ganglia lesions, frequently due to toxoplasmosis. Antiparasitic therapy can improve these symptoms, particularly hemiballismus-hemichorea.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Movement Disorders

Background:

  • Acquired Immunodeficiency Syndrome (AIDS) can manifest with neurological complications, including movement disorders.
  • Basal ganglia lesions are implicated in the pathogenesis of these movement disorders.

Observation:

  • Six patients with AIDS presented with diverse movement disorders: hemiballismus-hemichorea, athetosis, myoclonus, and tremor.
  • Brain imaging revealed corpus striatum lesions in all affected individuals.
  • Cerebral toxoplasmosis was the suspected diagnosis in the majority of cases.

Findings:

  • Hemiballismus-hemichorea was the most prevalent movement disorder observed.
  • Antiparasitic therapy led to improvement or resolution of movement disorders in patients with cerebral toxoplasmosis.

Related Experiment Videos

  • Patients with cerebral lymphoma or progressive multifocal leukoencephalopathy did not benefit from the treatments administered.

    • Implications:

    • Toxoplasmosis-induced basal ganglia lesions are a primary cause of movement disorders in AIDS patients.
    • Early diagnosis and antiparasitic treatment can potentially reverse or alleviate movement abnormalities in AIDS.
    • Understanding the link between specific opportunistic infections and neurological deficits is crucial for managing AIDS patients.